Methylenetetrahydrofolate reductase gene polymorphism and homocysteine level in patients with pseudoexfoliation and pseudoexfoliation glaucoma in southern Iran

Iranian Red Crescent Medical Journal

Volumn 11, Issue 4, 2009, Pages 445-449

  Talebnejad, Mohammad Reza ^a   Mosallaei, M ^a   Azarpira, N ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gene; Polymorphism; Pseudoexfoliation; Pseudoexfoliation glaucoma

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; GLAUCOMA; HUMAN; HYPERHOMOCYSTEINEMIA; IRAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PSEUDOEXFOLIATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 73649125877     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Altintaş O, Maral H, Yüksel N, Karabaş VL, Dillioǧlugil MO, Caǧlar Y. Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary openangle glaucoma. Graefes Arch Clin Exp Ophthalmol 2005;243:677-83. [15688159] [doi:10.1007/s00417-004-1097-2]
2. Andrikopoulos GK, Mela EK, Georgakopoulos CD, Papadopoulos GE, Damelou AN, Alexopoulos DK, Gartaganis SP. Pseudoexfoliation syndrome prevalence in Greek patients with cataract and its association to glaucoma and coronary artery disease. Eye 2009;23:442-7. [1793 2505] [doi:10.1038/sj.eye. 6702992]
3. Hepsen IF, Yaǧci R, Keskin U. Corneal curvature and central corneal thickness in eyes with pseudoexfoliation syndrome. Can J Ophthalmol 2007;42:677-80. [17891195] [doi:10.3129/I07-145]
4. Martone G, Casprini F, Traversi C, Lepri F, Pichierri P, Caporossi A. Pseudoexfoliation syndrome: in vivo confocal microscopy analysis. Clin Experiment Ophthalmol 2007;35:582-5. [17760643] [doi:10.1111/j.1442- 9071.2007.01535.x]
5. Damji KF. Progress in understanding pseudoexfoliation syndrome and pseudoexfoliation-associated glaucoma. Can J Ophthalmol 2007;42:657-8. [17891191] [doi:10.3129/I07-158]
6. Lopez-Martinez F, Lopez-Garrido MP, Sanchez-Sanchez F, Campos-Mollo E, Coca-Prados M, Escribano J. Role of MYOC and OPTN sequence variations in Spanish patients with primary Open-angle glaucoma. Mol Vis 2007;13:862- 72. [17615537]
7. Roedl JB, Bleich S, Reulbach U, von Ahsen N, Schlötzer-Schrehardt U, Rejdak R, Naumann GO, Kruse FE, Kornhuber J, Jünemann AG. Homocysteine levels in aqueous humor and plasma of patients with primary open-angle glaucoma. J Neural Transm 2007;114:445-50. [16932990] [doi:10.1007/s00702- 006-0556-9]
8. Bleich S, Jünemann A, von Ahsen N, Lausen B, Ritter K, Beck G, Naumann GO, Kornhuber J. Homocysteine and risk of open-angle glaucoma. J Neural Transm 2002;109:1499-504. [12486490] [doi:10.1007/ s007020200097]
9. Turacli ME, Tekeli O, Ozdemir F, Akar N. Methylenetetrahydrofolate reductase 677 C-T and homocysteine levels in Turkish patients with pseudoexfoliation. Clin Experiment Ophthalmol 2005; 33:505-8. [16181277] [doi:10.1111/j.1442-9071.2005.01070.x]
10. Roedl JB, Bleich S, Reulbach U, Rejdak R, Naumann GO, Kruse FE, Schlötzer-Schrehardt U, Kornhuber J, Jünemann AG. Vitamin deficiency and hyperhomocysteinemia in pseudoexfoliation glaucoma. J Neural Transm 2007;114:571-5. [17238009] [doi:10.1007/s00702-006-0598-z]
11. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000;96:762-4. [11121176] [doi:10.1002/1096-8628(20001204)96:6〈762::AID-AJMG12〉3.0. CO;2-X]
12. Fingert JH, Kwon YH, Moore PA, et al. The C677T variant in the methylenetetrahydrofolate reductase gene is not associated with disease in cohorts of pseudoexfoliation glaucoma and primary open-angle glaucoma patients from Iowa. Ophthalmic Genet 2006;27:39-41. [16754204] [doi:10.1080/13816810600677883]
13. Leibovitch I, Kurtz S, Shemesh G, Goldstein M, Sela BA, Lazar M, Loewenstein A. Hyperhomocystinemia in pseudoexfoliation glaucoma. J Glaucoma 2003;12:36-9. [12567109] [doi:10.1097/00061198-200302000- 00007]
14. Vessani RM, Ritch R, Liebmann JM, Jofe M. Plasma homocysteine is elevated in patients with exfoliation syndrome. Am J Ophthalmol 2003;136:41-6. [12834668] [doi:10.1016/S0002-9394(03)00077-1]
15. Righetti M. Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients. Clin Chem Lab Med 2007;45:1586-9. [17937606] [doi:10.1515/CCLM.2007.335]
16. Piovesan F, Veronese FJ, Santos AF, Pozza R, Sarturi PS, Tognon A, Garcia VD, Keitel E, Saitovitch D. Serum homocysteine levels in renal transplant recipients with and without hypercholesterolemia. Arq Bras Cardiol 2007;89:154-9. [17906816]
17. Christopher R, Nagaraja D, Shankar SK. Homocysteine and cerebral stroke in developing countries. Curr Med Chem 2007;14:2393-401. [17896987] [doi:10.2174/092986707781745613]
18. Jakubowski H. The molecular basis of homocysteine thiolactone-mediated vascular disease. Clin Chem Lab Med 2007;45:1704-16. [17937605] [doi:10.1515/CCLM.2007.338]
19. Di Rosa G, Attinà S, Spanò M, Ingegneri G, Sgrò DL, Pustorino G, Bonsignore M, Trapani-Lombardo V, Tortorella G. Efficacy of folic acid in children with migraine, hyperhomocysteinemia and MTHFR polymorphisms. Headache 2007;47:1342-4. [17927652] [doi:10.1111/j.1526-4610.2007. 00932.x]
20. Bushnell CD, Goldstein LB. Neurologists' evaluation and treatment of hyperhomocysteinemia in stroke Patients. J Stroke Cerebrovasc Dis 2005;14:101-6. [17904008] [doi:10.1016/j.jstrokecerebrovasdis.2005.01. 003]